OR WAIT null SECS
Cheryl Barton is director of PharmaVision, info@pharmavision.co.uk.
January 02, 2024
The EHDS aims to increase access to health data, but how will it impact pharma?
December 02, 2023
What does the 2024 VPAS mean for pharma?
November 02, 2023
New radiotherapeutic agents are making headway in hard-to-treat cancers.
September 28, 2023
The new framework will position the UK as an attractive prospect for new medicine manufacturers.
September 03, 2023
Tumour-infiltrating lymphocyte (TIL) therapies offer a new route to target cancer.
August 02, 2023
What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?